Zobrazeno 1 - 10
of 20
pro vyhledávání: '"J M Clerc"'
Autor:
A. Mezier, P. Motreff, J. M. Clerc, O. Bar, R. Deballon, T. Demicheli, T. Dechery, G. Souteyrand, A. Py, N. Lhoest, T. Lhermusier, B. Honton, A. Gommeaux, J. Jeanneteau, P. Deharo, H. Benamer, G. Cayla, R. Koning, B. Pereira, J. P. Collet, G. Rangé
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Backgroundwhile the duration of dual antiplatelet therapy (DAPT) following coronary angioplasty for chronic coronary syndrome (CCS) recommended by the European Society of Cardiology has decreased over the last decade, little is known about the adhere
Externí odkaz:
https://doaj.org/article/bfddd8b330ab4fe08cc496299678a8b8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christophe David, M. Lacout, J M Clerc, A Bernard, C Saint Etienne, C. Caze, F Dion, L Quilliet
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. Introduction Aortic Stenosis (AS) is a common condition in patients over 75 years. Latest ESC recommendations differentiate 4 types of AS according to: Indexed Stroke Volume (SVi), mean gradient
Autor:
D Babuty, Thibaud Lacour, Fabrice Ivanes, Thierry Bourguignon, J M Clerc, L Fauchier, Alexandre Bodin, L Quilliet, A Bernard, Arnaud Bisson, Pierre Deharo, Julien Herbert, C Saint Etienne
Publikováno v:
European Heart Journal. 41
Background Prediction of operative risk in patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) remains a challenge, particularly in high-risk patients. The EuroSCORE
Autor:
L Fauchier, Arnaud Bisson, L Quilliet, Thibaud Lacour, Pierre Deharo, K Semaan, Nicolas Clementy, Alexandre Bodin, J M Clerc, Fabrice Ivanes, Bertrand Pierre, Julien Herbert, Dominique Babuty, C Saint Etienne
Publikováno v:
European Heart Journal. 41
Background Conduction abnormalities leading to permanent pacemaker (PPM) implantation are common complications following transcatheter aortic valve replacement (TAVR). Whether PPM implantation placement is associated with adverse outcomes is unclear.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B. Desveaux, J Bouteau, C Saint Etienne, Fabrice Ivanes, C. Caze, L Quilliet, Thierry Bourguignon, J M Clerc
Publikováno v:
European Heart Journal. 40
Objective Transcatheter Aortic Valve Replacement (TAVI) has become the reference procedure in intermediate or high surgical risk patients with degenerative aortic stenosis. Vascular complications are associated with poorer outcomes in patients after
Autor:
C Saint Etienne, Arnaud Bisson, Denis Angoulvant, L Quilliet, A Bernard, Julien Herbert, Thierry Bourguignon, J M Clerc, Pierre Lantelme, L Guillon Grammatico, Fabrice Ivanes, D Babuty, Thibaud Lacour, L Fauchier
Publikováno v:
European Heart Journal. 40
Risk-benefit assessment for transcatheter aortic valve replacement (TAVR) is still a matter of debate. A sizeable group of patients do not fully benefit from intervention despite a technically successful procedure. We therefore sought to identify pat
Autor:
Thierry Bourguignon, Arnaud Bisson, J M Clerc, Fabrice Ivanes, C Saint Etienne, Julien Herbert, L Quilliet, D Babuty, Thibaud Lacour, L Guillon Grammatico, Denis Angoulvant, A Bernard, L Fauchier
Publikováno v:
European Heart Journal. 40
Patients undergoing transcatheter aortic valve replacement (TAVR) may have concomitant mitral regurgitation (MR). The impact of MR at baseline or after TAVR on subsequent prognosis remains to be more precisely determined. We analysed the impact of MR
Autor:
R. Bensaid, C. Saint-Etienne, C. Caze, Thierry Bourguignon, J M Clerc, Fabrice Ivanes, David Ternant, B. Desveaux, L Quilliet
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:89
Background The impact of significant coronary lesions at the time of transcatheter aortic-valve replacement (TAVR) is contradictory according to the literature. Management of these lesions remains controversial before TAVR. Purpose To compare the pro